Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
- PMID: 30201879
- PMCID: PMC6165515
- DOI: 10.3390/diseases6030080
Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
Abstract
Our aim is to review the efficacy of various herbs and supplements as a possible therapeutic option in the treatment and/or prevention of nonalcoholic fatty liver disease (NAFLD). We performed a systematic review of medical literature using the PubMed Database by searching the chemical names of many common herbs and supplements with "AND (NAFLD or NASH)". Studies and medical literature that discussed the roles and usage of herbs and supplements in NAFLD and nonalcoholic steatohepatitis (NASH) from inception until 20 June 2018 were reviewed. Many studies have claimed that the use of various herbs and supplements may improve disease endpoints and outcomes related to NAFLD and/or NASH. Improvement in liver function tests were noted. Amelioration or reduction of lobular inflammation, hepatic steatosis, and fibrosis were also noted. However, well-designed studies demonstrating improved clinical outcomes are lacking. Furthermore, experts remain concerned about the lack of regulation of herbs/supplements and the need for further research on potential adverse effects and herb⁻drug interactions. In conclusion, preliminary data on several herbs have demonstrated promising antioxidant, anti-inflammatory, anti-apoptotic, and anti-adipogenic properties that may help curtail the progression of NAFLD/NASH. Clinical trials testing the safety and efficacy must be completed before widespread can be recommended.
Keywords: Ginkgo biloba; NAFLD; NASH; cannabinoids; coffee; fish oil; garlic; green tea; herb; nonalcoholic fatty liver disease; resveratrol; silymarin; turmeric.
Conflict of interest statement
The authors declare no conflict of interest, including financial and/or material support for the preparation of this manuscript.
Similar articles
-
The Role of Vitamin E in the Treatment of NAFLD.Diseases. 2018 Sep 24;6(4):86. doi: 10.3390/diseases6040086. Diseases. 2018. PMID: 30249972 Free PMC article. Review.
-
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD.Diseases. 2019 Feb 25;7(1):27. doi: 10.3390/diseases7010027. Diseases. 2019. PMID: 30823570 Free PMC article. Review.
-
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.World J Gastroenterol. 2015 Apr 7;21(13):3777-85. doi: 10.3748/wjg.v21.i13.3777. World J Gastroenterol. 2015. PMID: 25852263 Free PMC article. Review.
-
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539. World J Gastroenterol. 2014. PMID: 25400438 Free PMC article. Review.
-
Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.Cells. 2019 Oct 15;8(10):1259. doi: 10.3390/cells8101259. Cells. 2019. PMID: 31619023 Free PMC article. Review.
Cited by
-
Exploring diet associations with Covid-19 and other diseases: a Network Analysis-based approach.Med Biol Eng Comput. 2022 Apr;60(4):991-1013. doi: 10.1007/s11517-022-02505-3. Epub 2022 Feb 16. Med Biol Eng Comput. 2022. PMID: 35171411 Free PMC article.
-
Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease.Antioxidants (Basel). 2021 Dec 30;11(1):91. doi: 10.3390/antiox11010091. Antioxidants (Basel). 2021. PMID: 35052595 Free PMC article. Review.
-
Supplementation of Silymarin Alone or in Combination with Salvianolic Acids B and Puerarin Regulates Gut Microbiota and Its Metabolism to Improve High-Fat Diet-Induced NAFLD in Mice.Nutrients. 2024 Apr 14;16(8):1169. doi: 10.3390/nu16081169. Nutrients. 2024. PMID: 38674860 Free PMC article.
-
Platycodi Radix Extract Prevents Hepatic Steatosis by Enhancing Bile Acid Synthesis in a High-Fat Diet-Induced Fatty Liver Mouse Model.Nutrients. 2024 Mar 20;16(6):893. doi: 10.3390/nu16060893. Nutrients. 2024. PMID: 38542804 Free PMC article.
-
New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products.ILIVER. 2024 Nov 8;3(4):100131. doi: 10.1016/j.iliver.2024.100131. eCollection 2024 Dec. ILIVER. 2024. PMID: 40635852 Free PMC article. Review.
References
-
- Blond E., Disse E., Cuerq C., Drai J., Valette P.J., Laville M., Thivolet C., Simon C., Caussy C. Easl-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: Do they lead to over-referral? Diabetologia. 2017;60:1218–1222. doi: 10.1007/s00125-017-4264-9. - DOI - PubMed
-
- Chalasani N., Younossi Z., Lavine J.E., Diehl A.M., Brunt E.M., Cusi K., Charlton M., Sanyal A.J., American Gastroenterological Association. American Association for the Study of Liver Diseases et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American gastroenterological association, American association for the study of liver diseases, and American college of gastroenterology. Gastroenterology. 2012;142:1592–1609. doi: 10.1053/j.gastro.2012.04.001. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources